ZNF687 levels were positively related to clinical characteristics, including lymph node‐positive (p = 0.0445), cancer grade (p = 0.0293), lymphatic metastasis (p = 0.0325), and medical stages (AJCC 7th) (p = 0.0253), indicating that ZNF687 overexpression was an independent risk variable for poor outcomes (Table 3). This evidence concerns the gene ZNF687 and cancer.